LIM2 and cancer: The results of the CCK-8, EdU, transwell, and scratch assays revealed that deletion of the LIM4 domain of FHL3 significantly reduced the cancer-promoting function of FHL3, whereas deletion of the LIM2 or LIM3 domain had little effect on the cancer-promoting function of FHL3 (Fig. S4B–E).